Donald Kohn

Jan 24, 2025 | brookings.edu | Donald Kohn

When Federal Reserve Chair Jerome Powell kicked off the promised every-five-year review of the Fed’s “monetary policy strategy, tools, and communications” at the annual Jackson Hole conference in August 2024, he noted “…that the pandemic economy has proved to be unlike any other, and that there remains much to be learned from this extraordinary period.” He acknowledged that “the limits of our knowledge—so clearly evident during the pandemic—demand humility and a questioning spirit focused on...

Jul 25, 2024 | brookings.edu | Donald Kohn

Editor's note: This essay was prepared for the May 2024 NBER conference “Inflation in the COVID Era and Beyond.” The Romer and Romer paper it discusses, “Lessons from history for successful disinflation,” may be read here.

May 22, 2024 | brookings.edu | Janice Eberly |Donald Kohn |Jón Steinsson |Pierre Yared

Most advanced economies enjoyed a long period of low, stable inflation prior to 2021, with inflation in the U.S. actually running below the Federal Reserve’s 2% inflation target for much of the 2010s. This stability was driven in part by factors external to monetary policy, including downward price and wage pressures from globalization and de-unionization.

Nov 30, 2023 | onlinelibrary.wiley.com | Donald Kohn

CONFLICT OF INTEREST STATEMENT D.B. Kohn is an inventor for the University of California (UC) Regents for the EFS-ADA lentiviral vector discussed here. He was a compensated member of the Scientific Advisory Board for Orchard Therapeutics that had licensed the EFS-ADA program from the UC Regents. He has been an advisor to Chiesi USA on recombinant ADA enzyme replacement therapy. REFERENCES 1, , , , . Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity.

Nov 7, 2023 | nature.com | Donald Kohn

AbstractDespite the ups and downs in the field over three decades, the science of gene therapy has continued to advance and provide enduring treatments for increasing number of diseases. There are active clinical trials approaching a variety of inherited and acquired disorders of different organ systems.